Search Result "CCI779"

Research Article

Combined Treatment with CCI779 and SB203580 Induces Cellular Senescence in Renal Cell Carcinoma Cell Line via p53 Pathway

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 11 Year: 2017 Page: 1545-1554
Author(s): Ashutosh Chauhan,Rani Ojha,Deepak K. Semwal,Satyendra P. Mishra,Ruchi B. Semwal

Review Article

Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang

Perspectives on mTOR Inhibitors for Castration-Refractory Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 8 Year: 2012 Page: 940-949
Author(s): Salvatore L. Burgio,Francesco Fabbri,Ian J. Seymour,Wainer Zoli,Dino Amadori,Ugo De Giorgi

Recent Patents on Melanoma with Focus on Genetic Strategies

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 3 Issue: 2 Year: 2008 Page: 136-144
Author(s): Talia Gramiccia, Rosita Saraceno, Alessandro D. Stefani, Sergio Chimenti, Alessandro Di Stefani

Neurological Complications of Antiangiogenic Therapy

Ebook: Anti-Angiogenesis Drug Discovery and Development
Volume: 1 Year: 2011
Author(s): Jose Tarcisio Feitosa Vieira da Silva,Italo Gustavo Lima Monteiro,Carlos Tairo Diogenes Holanda,Francisco de Assis Aquino Gondim
Doi: 10.2174/978160805162511101010148

The Akt-mTOR Pathway in Down’s Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 34-40
Author(s): Jose Antonio Troca-Marin,Juan Jose Casanas,Itziar Benito,Maria Luz Montesinos

Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma

Journal: Current Molecular Medicine
Volume: 15 Issue: 1 Year: 2015 Page: 82-93
Author(s): V. Dimitrova,A. Arcaro

Research Article

Inhibition of IL-2 Production by Novel Small Molecules using Building Blocks from Reduced Chalcones and a Substituted Proline

Journal: Current Drug Therapy
Volume: 13 Issue: 2 Year: 2018 Page: 130-139
Author(s): Esteban F. Duran-Lara,Wender A. da Silva,Luis Guzman,Ricardo Castro,Carlos Kleber Z. Andrade,Leonardo S. Santos

Disrupting the mTOR Signaling Network as a Potential Strategy for the Enhancement of Cancer Radiotherapy

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 8 Year: 2012 Page: 899-924
Author(s): Francis J. Dumont,Pierre Bischoff

Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 3 Year: 2013 Page: 464-475
Author(s): Jinjia Chang,Weimin Fan

Previous   Next

Go To   Results 1 - 1 of 23

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy